12/29/2020 6:31:33 AM
MediciNova Receives Notice Of Allowance For New Patent Covering MN-166
11/25/2020 6:33:11 AM
MediciNova Announces Positive Optical Coherence Tomography Results From SPRINT-MS Phase 2b Trial Of MN-166
10/21/2020 6:34:19 AM
MediciNova Appoints Carolyn Beaver To Its Board
9/24/2020 6:34:39 AM
MediciNova: Positive Clinical Findings Published In Cancer Chemotherapy And Pharmacology On MN-166
9/23/2020 6:45:58 AM
MediciNova Says Intranasal BC-PIV SARS-CoV-2 Vaccine Induced Systemic IgG & Mucosal IgA Neutralizing Antibodies In Mice
9/23/2020 6:45:13 AM
MediciNova: Intranasal BC-PIV SARS-CoV-2 Vaccine Induced Systemic IgG And Mucosal IgA Neutralizing Antibodies In Mice
9/11/2020 6:38:58 AM
BioComo: Intranasal RS Virus Vaccine Induced Neutralizing Antibodies Against RS Virus In Mice Using BC-PIV Technology
7/27/2020 6:53:12 AM
MediciNova Enters Agreement With BioComo, Mie University For Joint Development Of SARS-CoV-2 Vaccine
7/1/2020 6:44:50 AM
MediciNova Says IND For MN-166 For Prevention Of Acute Respiratory Distress Syndrome Accepted And Is Now Open With FDA